NEWS!! Veritas-Cannavert Commences Preparation Of First Clinical Trials Of Cannabis Targeting Pain
February 7, 2017 Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), an emerging discovery and IP development company, is pleased to announce that Dr. Ricardo Rivera Acevedo, a scientist within its research arm, Cannevert Therapeutics Ltd., has been invited to attend the Masterclass on Medicinal Cannabis in Leiden, The Netherlands from March 5-10, 2017.
Bedrocan, a multinational company that has been growing and supplying pharmaceutical grade medicinal cannabis since the early 1980s, hosts this 5-day seminar yearly. The selection process involves selecting from an international pool of applicants with diverse backgrounds and research interests from the industry. Bedocran’s Head of Research and Education, Dr. Arno Hazekamp, has brought together several world experts to review the historical significance, regulatory status, chemical composition, clinical research designs, quality control/assurance matters, and latest cultivation techniques related to medicinal cannabis.
Veritas CEO, Dr. Lui Franciosi stated that “We are very pleased to have one of the Cannevert scientists attend this event. It demonstrates Bedrocan’s interest in our scientific approach of using functional techniques to assess the potential of whole plant extracts for specific disease conditions. This event will maximize the exchange of best practices between professionals, including policy makers, who are actively involved in the medicinal cannabis industry.”